Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis after Coronary Angioplasty

Circulation

Volumn 108, Issue 22, 2003, Pages 2776-2782

  Cipollone, Francesco ^a,d   Ferri, Claudio ^b   Desideri, Giovambattista ^b   Paloscia, Leonardo ^c   Materazzo, Guido ^c   Mascellanti, Marco ^c   Fazia, Maria ^a   Iezzi, Annalisa ^a   Cuccurullo, Chiara ^a   Pini, Barbara ^a   Bucci, Marco ^a   Santucci, Anna ^b   Cuccurullo, Franco ^a   Mezzetti, Andrea ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c SPIRITO SANTO HOSPITAL   (Italy)

^d Nuovo Policlinico SS Annunziata   (Italy)

Author keywords

Angioplasty; Endothelium; Inflammation; Platelets; Restenosis

Indexed keywords

ACETYLSALICYLIC ACID; CD40 ANTIGEN; CD40 LIGAND; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN; PENAM DERIVATIVE; SOLUBLE CD40 LIGAND; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE VASCULAR CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MONONUCLEAR CELL; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; RESTENOSIS; THROMBOCYTE ACTIVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CD40 LIGAND; CELL MOVEMENT; CHEMOKINE CCL2; CORONARY RESTENOSIS; CORONARY STENOSIS; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MONOCYTES; PREDICTIVE VALUE OF TESTS; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 10744230698     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000103700.05109.0D     Document Type: Article

References (20)

1. Pietersma A, Kofflard M, De Wit EA, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995;91:1320-1325.
2. Buffon A, Liuzzo G, Biasucci LM, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol. 1999;34:1512-1521.
3. Zhou YF, Csako G, Grayston JT, et al. Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae. Am J Cardiol. 1999;84:595-598.
4. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591-594.
5. Mach F, Schönbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implication for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A. 1997;94:1931-1936.
6. Mach F, Schönbeck U, Sukhova GK, et al. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998;394:200-203.
7. Aukrust P, Müller F, Ueland T, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Circulation. 1999;100:614-620.
8. Cipollone F, Mezzetti A, Porreca E, et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation. 2002;106:399-402.
9. Schönbeck U, Varo N, Libby P, et al. Soluble CD40L and cardiovascular risk in women. Circulation. 2001;104:2266-2268.
10. André P, Nannizzi-Alaimo L, Prasad SK, et al. Plate let-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation. 2002; 106:896-899.
11. André P, Prasad KS, Denis CV, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med. 2002;8:247-252.
12. Urbich C, Dernbach E, Sicher A, et al. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation. 2002;106:981-986.
13. Cipollone F, Marini M, Fazia M, et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2001;21:327-334.
14. Yasukawa H, Imaizumi T, Matsuoka H, et al. Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. Circulation. 1997;95:1515-1522.
15. Desideri G, Ferri C, Bellini C, et al. Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion. Diabetes. 1997;46:81-86.
16. 1-dependent oxidant-sensitive decrement of nitric oxide availability. Arterioscler Thromb Vasc Biol. 2003;23:1218-1223.
17. Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation. 1997;96:1109-1116.
18. Cipollone F, Ciabattoni G, Patrignani P, et al. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation. 2000;102:1007-1013.
19. Serrano CV Jr, Ramires JA, Venturinelli M, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression: evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol. 1997;29:1276-1283.
20. Dibra A, Mehilli J, Braun S, et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med. 2003;114:715-722.